Carboplatin

This classification denotes a platinum compound with the molecular formula C6H6O4.Pt.2H3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BG3F62OND5, chemically known as cis-diammine(1,1-cyclobutanedicarboxylato) platinum but more generally known as carboplatin, which bears US NIH Compound Identifier 38904. European Medicines Agency schedules Carboplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06614MIG. The term CARBOPLATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules carboplatin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule carboplatin under HS 28439090 and SITC 52432. As of Q4 2014, CARBOPLATIN remains US FDA's Preferred Term for this commodity. Carboplatin bears US NLM identifiers UMLS ID C0079083 and NCI Concept Code C1282. SMILES: [Pt]1[OH]C(=O)C2(CCC2)C(=O)[OH]1.N.N.